Explore our insights

This publication covers the performance of the pharma and healthcare sector in Q3.

While India is on target to achieve a fiscal deficit of 6.4 per cent this financial year, significant efforts are needed to meet the target of 4.5 per cent set for FY26

In Budget 2023, healthcare was among the focal sectors with an emphasis on digital innovation

Grant Thornton Bharat - AHPI report delves deep into understanding technology transformation in the Indian healthcare industry

Budget for healthcare

Budget 2023: Pharma sector expectations

Bhanu Prakash Kalmath S J and Karan Kakkar explain the GST rate of 5% that has been levied on hospital room charges and what are some critical points to ponder.

Bhanu Prakash Kalmath S J, talks about why the skills shortage, in the life sciences sector, requires a strategic approach by senior leadership.

Bhanu Prakash Kalmath and Biren Vyas share their views on the government’s vision of Aatmanirbhar Bharat and how the pharma sector can play a key role in this.

Bhanu Prakash Kalmath and Karan Kakkar write about the 5 key expectations from the healthcare sector, this Budget.

To gauge the market sentiments and better understand the expectations from Union Budget 2022, Grant Thornton Bharat conducted a survey for healthcare sector.

To gauge the market sentiments and better understand the expectations from Union Budget 2022, Grant Thornton Bharat conducted a survey for pharma sector.

A snapshot of PE activities from Half-yearly Dealtracker

A snapshot of M&A activities in H1 2021 and growth prospects for H2 2021

The ongoing COVID-19 crisis has severely strained the hospital infrastructure, as the disease has claimed over 100,000 lives in less than three months with many infected countries yet to hit their peaks in number of cases.

As the coronavirus disease (COVID-19) pandemic disrupts global value chains, the Indian pharmaceutical industry is staring at multiple challenges.